HLF · XBRL financial data
Herbalife financial statements, every quarter
The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal quarters (HLF's year ends in late December)
| In millions of dollars | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 | Sep 30, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from contracts with customers | 1,215* | 1,264 | 1,281 | 1,240 | 1,207* | 1,222 | 1,259 | 1,274 | 1,283* | 1,317 | 1,327 | 1,350 |
| Cost of goods and services sold | 288* | 285 | 283 | 269 | 268* | 265 | 277 | 284 | 288* | 291 | 296 | 306 |
| Gross profit | 927* | 979 | 998 | 972 | 940* | 957 | 982 | 990 | 995* | 1,026 | 1,031 | 1,044 |
| Selling, general and administrative | 474* | 492 | 502 | 444 | 437* | 432 | 448 | 448 | — | — | — | — |
| General and administrative | year only | — | — | — | year only | 400 | 409 | 413 | 443* | 431 | 436 | 432 |
| Other operating income (expense) | 0* | 0 | 0 | 5 | 1* | 0 | 5 | 0 | 0* | 6 | 0 | 0 |
| Operating income (loss) | 56* | 72 | 80 | 127 | 107* | 123 | 133 | 126 | 100* | 138 | 128 | 139 |
| Interest expense | 50* | 38 | 58 | 57 | 66* | 52 | 54 | 51 | 58* | 47 | 37 | 32 |
| Other income (expense) | 0* | — | (11) | 0 | 0* | — | 0 | 0 | 0* | — | (95) | 0 |
| Income tax expense (benefit) | 8* | 10 | 8 | 23 | (125)* | 20 | 30 | 32 | (35)* | 30 | 23 | 50 |
| Net income (loss) | 10* | 24 | 5 | 47 | 178* | 50 | 49 | 43 | 85* | 62 | (26) | 59 |
| Earnings per share, basic USD per share | 0.10* | 0.24 | 0.05 | 0.47 | 1.76* | 0.50 | 0.48 | 0.42 | 0.82* | 0.60 | (0.25) | 0.56 |
| Earnings per share, diluted USD per share | 0.10* | 0.24 | 0.05 | 0.46 | 1.74* | 0.49 | 0.48 | 0.42 | 0.81* | 0.57 | (0.25) | 0.55 |
| Weighted average shares, basic millions of shares | 99* | 100 | 101 | 101 | 101* | 102 | 103 | 103 | 104* | 104 | 105 | 105 |
| Weighted average shares, diluted millions of shares | 101* | 101 | 102 | 102 | 102* | 102 | 103 | 104 | 105* | 108 | 105 | 107 |
Balance sheet
CSVFiscal quarters (HLF's year ends in late December)
Cash flows
CSVFiscal quarters (HLF's year ends in late December)
| In millions of dollars | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 | Sep 30, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (loss) | 10* | 24 | 5 | 47 | 178* | 50 | 49 | 43 | 85* | 62 | (26) | 59 |
| Stock-based compensation | 12* | 12 | 12* | 13* | 13* | 12 | 10* | 11* | 11* | 11 | 10* | 9* |
| Net cash from operating activities | 96* | 14 | 103* | 100* | 70* | 0 | 96* | 139* | 98* | 114 | 33* | 151* |
| Purchases of property and equipment | 35* | 33 | 36* | 27* | 26* | 18 | 23* | 21* | 19* | 11 | 11* | 19* |
| Net cash from investing activities | (35)* | (33) | (36)* | 10* | (26)* | (19) | (51)* | (21)* | (19)* | (11) | (22)* | (19)* |
| Share repurchases | 1* | 2 | 3* | 0* | 3* | 2 | 5* | 1* | 0* | 1 | 9* | 0* |
| Net cash from financing activities | 8* | (158) | (82)* | (86)* | (9)* | (72) | (60)* | (130)* | (33)* | 2 | (83)* | (90)* |
| Net change in cash | 80* | (183) | (23)* | 29* | 20* | (87) | (7)* | (16)* | 47* | 98 | (80)* | 39* |
Compare with peers
SIC 5122 and related industry codes, similar size; rows marked “added: same SIC” fill a short list. Each row is the latest quarter reported.
How peers are chosen
- SIC 5122 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Fewer than three companies fall in that range, so the list adds same-SIC (5122) companies nearest in public float, each marked “added: same SIC”.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
- A cell reading “year only” links to a 10-K that gives only the full year: without all three earlier quarters there is no fourth quarter to work out, and the year total is never shown as a quarter.
| Company | Cash ($M) | Revenue, quarter ($M) | Operating cash flow, quarter ($M) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| Herbalife | 409 | 1,350 | 151* | 104.9M | — | 10-QSep 30, 2026 |
| Nu Skin Enterprises | 190 | 320 | 11* | 48.7M | — | 10-QJun 30, 2026 |
| DataMeds AIadded: same SIC | 2.5 | 1.8 | (2.9)* | 3.1M | 0.8 quarters | 10-QJun 30, 2026 |
| Cencoraadded: same SIC | 2,815 | 84,755 | 2,654* | 190.8M | — | 10-QJun 30, 2026 |
| Cardinal Healthadded: same SIC | 4,856 | year only | year only | 232.6M | — | 10-KJun 30, 2026 |
| Cosmos Healthadded: same SIC | 1.8 | 19 | (1.7)* | 100.6M | 1.1 quarters | 10-QJun 30, 2026 |
| McKessonadded: same SIC | 5,164 | 105,380 | (220) | 116.6M | — | 10-QJun 30, 2026 |
| Stemtechadded: same SIC | 0.2 | 0.6 | (0.1)* | 3.0B | 4.5 quarters | 10-QJun 30, 2026 |
| HWH Internationaladded: same SIC | 1.5 | 0.1 | 0.5* | 7.7M | — | 10-QJun 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.